Pathobiology of Respiratory Syncytial Virus (RSV).


Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
09 Jul 2020
Historique:
received: 24 06 2020
accepted: 06 07 2020
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 15 7 2020
Statut: epublish

Résumé

Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract illness in infants and affects the elderly and the immune-compromised [...].

Identifiants

pubmed: 32659977
pii: vaccines8030367
doi: 10.3390/vaccines8030367
pmc: PMC7565515
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

Vaccines (Basel). 2020 Apr 21;8(2):
pubmed: 32326278
Vaccines (Basel). 2020 Apr 26;8(2):
pubmed: 32357557
Vaccines (Basel). 2019 Sep 06;7(3):
pubmed: 31500131
Vaccines (Basel). 2020 Apr 10;8(2):
pubmed: 32290326
Vaccines (Basel). 2020 Mar 18;8(1):
pubmed: 32197348

Auteurs

Ralph A Tripp (RA)

Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.

Paul S McNamara (PS)

Department of Child Health, University of Liverpool, Liverpool L69 3BX, UK.

Classifications MeSH